U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1998
123
Substance Class
Concept
Record UNII
DQ448MW7KS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PALIVIZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
PALIVIZUMAB [EMA EPAR]
Preferred Name English
PALIVIZUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS PROTEIN F)(HUMAN-MOUSE MONOCLONAL MEDI-493 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-493 .KAPPA.-CHAIN, DIMER
Common Name English
PALIVIZUMAB [USAN]
Common Name English
Palivizumab [WHO-DD]
Common Name English
PALIVIZUMAB [MART.]
Common Name English
PALIVIZUMAB [PURPLE BOOK CDER]
Common Name English
PALIVIZUMAB [VANDF]
Common Name English
palivizumab [INN]
Common Name English
PALIVIZUMAB [JAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS PROTEIN F)(HUMAN-MOUSE MONOCLONAL MEDI-493 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MEDI-493 .KAPPA.-CHAIN, DIMER
Common Name English
SYNAGIS
Brand Name English
Classification Tree Code System Code
NDF-RT N0000011174
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
NDF-RT N0000175623
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
NDF-RT N0000011174
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
NDF-RT N0000011174
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
NDF-RT N0000175615
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
WHO-ATC J06BB16
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
Code System Code Type Description
RXCUI
194279
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY RxNorm
CAS
188039-54-5
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
NCI_THESAURUS
C2625
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
DAILYMED
DQ448MW7KS
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
MERCK INDEX
m8359
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY Merck Index
DRUG BANK
DB00110
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
FDA UNII
DQ448MW7KS
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
INN
7753
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
DRUG CENTRAL
4935
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201586
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
HSDB
8178
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
SMS_ID
100000090252
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
USAN
JJ-55
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
MESH
C111186
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
LACTMED
Palivizumab
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
EVMPD
SUB03606MIG
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
WIKIPEDIA
PALIVIZUMAB
Created by admin on Wed Apr 02 09:25:15 GMT 2025 , Edited by admin on Wed Apr 02 09:25:15 GMT 2025
PRIMARY
This is a non-substance concept
Related Record Type Details
HUMAN RESPIRATORY SYNCYTIAL VIRUS
TARGET ORGANISM->INHIBITOR
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
Related Record Type Details
PALIVIZUMAB
ACTIVE MOIETY
This is a non-substance concept
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966